Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer. | Int J Cancer | 2021 | 33210294 | PubTator, text mining | PubMed |
| The X-linked intellectual disability gene product and E3 ubiquitin ligase KLHL15 degrades doublecortin proteins to constrain neuronal dendritogenesis. | J Biol Chem | 2021 | 33199366 | PubTator, text mining | PubMed |
| Abnormal Behavior and Cortical Connectivity Deficits in Mice Lacking Usp9x. | Cereb Cortex | 2021 | 33188399 | PubTator, text mining | PubMed |
| Protein complexes and neighborhoods driving autophagy. | Autophagy | 2021 | 33183148 | PubTator, text mining | PubMed |
| X-chromosome regulation and sex differences in brain anatomy. | Neurosci Biobehav Rev | 2021 | 33171144 | PubTator, text mining | PubMed |
| Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies. | Cancer Metastasis Rev | 2021 | 33106971 | PubTator, text mining | PubMed |
| Balancing the Opposing Principles That Govern Peroxisome Homeostasis. | Trends Biochem Sci | 2021 | 33046344 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities. | J Pathol | 2021 | 32901952 | PubTator, text mining | PubMed |
| Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. | Haematologica | 2021 | 32467145 | PubTator, text mining | PubMed |
| Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. | Semin Cancer Biol | 2021 | 31883910 | PubTator, text mining | PubMed |
| Right-angled vessels in macular telangiectasia type 2. | Br J Ophthalmol | 2021 | 30808615 | PubTator, text mining | PubMed |
| Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis. | Transl Cancer Res | 2020 | 35117787 | PubTator, text mining | PubMed |
| Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. | Transl Cancer Res | 2020 | 35117717 | PubTator, text mining | PubMed |
| Deubiquitination in prostate cancer progression: role of USP22. | J Cancer Metastasis Treat | 2020 | 34660907 | PubTator, text mining | PubMed |
| Development and application of ubiquitin-based chemical probes. | Chem Sci | 2020 | 34123237 | PubTator, text mining | PubMed |
| Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. | Nat Cancer | 2020 | 33796864 | PubTator, text mining | PubMed |
| Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer. | Front Oncol | 2020 | 33718111 | PubTator, text mining | PubMed |
| Recent advances in PTEN signalling axes in cancer. | Fac Rev | 2020 | 33659963 | PubTator, text mining | PubMed |
| Comprehensively Analyzed Macrophage-Regulated Genes Indicate That PSMA2 Promotes Colorectal Cancer Progression. | Front Oncol | 2020 | 33537240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=40